Twist Bioscience

Twist Bioscience

A DNA synthesis company using a next-generation silicon-based technology platform.

Edit ID  20347184 

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 26 Feb, 2021
Edits made to:
Article (+13/-13 characters)

On May 27 2014, Twist Bioscience completed a $26,000,000 series B funding roundfunding round. Investors include: DARPA, ARCH Venture Partners, Paladin Capital Group, Yuri Milner, and some undisclosed investors.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.